A Shahsafaei Selected Research

Squamous Cell Carcinoma (Epidermoid Carcinoma)

6/2000

Inhibition of translation initiation mediates the anticancer effect of the n-3 polyunsaturated fatty acid eicosapentaenoic acid.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

A Shahsafaei Research Topics

Disease

3	Neoplasms (Cancer) 07/2000 - 01/2000
1	Chronic Renal Insufficiency 02/2001
1	Segmental glomerulosclerosis 10/2000
1	Glandular and Epithelial Neoplasms (Neoplasms, Glandular) 09/2000
1	Thymoma (Thymic Carcinoma) 09/2000
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 07/2000
1	T-Cell Lymphoma (Lymphoma, T Cell) 07/2000
1	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 07/2000
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 06/2000
1	Adenocarcinoma 03/2000
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2000
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2000

Drug/Important Bio-Agent (IBA)

2	LigandsIBA 07/2000 - 01/2000
2	Chemokine ReceptorsIBA 07/2000 - 01/2000
1	candesartanIBA 02/2001
1	Enalapril FDA LinkGeneric 02/2001
1	N 30IBA 02/2001
1	Proteins (Proteins, Gene)FDA Link 10/2000
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2000
1	CytokinesIBA 10/2000
1	Histocompatibility Antigens Class IIIBA 09/2000
1	invariant chain (Ii-Key)IBA 09/2000
1	ParaffinIBA 09/2000
1	Anaplastic Lymphoma KinaseIBA 07/2000
1	Monoclonal AntibodiesIBA 07/2000
1	ChemokinesIBA 07/2000
1	CCR4 ReceptorsIBA 07/2000
1	Cyclin D1IBA 06/2000
1	Eicosapentaenoic AcidIBA 06/2000
1	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 06/2000

Therapy/Procedure

1	Nephrectomy 02/2001
1	Oral Administration 06/2000
1	Chemoradiotherapy 03/2000